tiprankstipranks
Cara Therapeutics (CARA)
NASDAQ:CARA
Holding CARA?
Track your performance easily

Cara Therapeutics (CARA) Stock Forecast & Price Target

2,262 Followers
See the Price Targets and Ratings of:

CARA Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Cara
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CARA Stock 12 Month Forecast

There Are No Analyst Ratings for CARA In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CARA Financial Forecast

CARA Earnings Forecast

The previous quarter’s earnings for CARA were -$0.23.
The previous quarter’s earnings for CARA were -$0.23.

CARA Sales Forecast

The previous quarter’s earnings for CARA were $2.56M.
The previous quarter’s earnings for CARA were $2.56M.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
$6$1
Hold
228.30%
Upside
Downgraded
06/13/24
Cara Therapeutics downgraded to Hold from Buy at StifelCara Therapeutics downgraded to Hold from Buy at Stifel
H.C. Wainwright
Hold
Downgraded
06/13/24
H.C. Wainwright downgrades Cara Therapeutics (CARA) to a Hold
Canaccord Genuity
$10$1
Hold
228.30%
Upside
Downgraded
06/12/24
Cara Therapeutics downgraded to Hold from Buy at CanaccordCara Therapeutics downgraded to Hold from Buy at Canaccord
Piper Sandler
$1
Hold
228.30%
Upside
Reiterated
05/14/24
Piper Sandler Sticks to Their Hold Rating for Cara Therapeutics (CARA)

CARA Analyst Recommendation Trends

Rating
Mar 24
Apr 24
May 24
Jun 24
Aug 24
Strong Buy
8
7
10
7
5
Buy
0
0
0
0
0
Hold
0
0
1
5
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
7
11
12
11
In the current month, CARA has received 5 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. CARA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CARA Stock Forecast FAQ

What is CARA’s average 12-month price target, according to analysts?
Currently, no data Available
What is CARA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CARA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CARA a Buy, Sell or Hold?
      Currently, no data Available
      What is Cara Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Cara Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CARA?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis